Chromosome 21, monosomy 21q22
Chromosome 21, monosomy 21q22 is a rare genetic disorder characterized by the deletion of a portion of the long arm (q) of chromosome 21, specifically in the region designated as 21q22. This condition is a type of chromosomal abnormality that can lead to various developmental and health issues in affected individuals. The symptoms and severity of the disorder can vary widely among patients, depending on the exact size and location of the deletion on chromosome 21.
Symptoms and Characteristics[edit | edit source]
Individuals with Chromosome 21, monosomy 21q22, may exhibit a range of physical, developmental, and intellectual disabilities. Common symptoms include but are not limited to:
- Intellectual disability or developmental delays
- Congenital heart defects
- Distinctive facial features
- Growth delays
- Muscle hypotonia (reduced muscle tone)
- Behavioral issues
It is important to note that the specific symptoms and their severity can vary significantly from one individual to another.
Causes[edit | edit source]
Chromosome 21, monosomy 21q22, is caused by a deletion of genetic material in the 21q22 region of chromosome 21. This deletion can occur randomly or may be inherited from a parent who carries a rearrangement of genetic material involving chromosome 21. The exact mechanism leading to the deletion and the reasons why it affects individuals differently are still under research.
Diagnosis[edit | edit source]
Diagnosis of Chromosome 21, monosomy 21q22 typically involves a combination of genetic testing and clinical evaluation. Genetic testing, such as karyotyping and fluorescence in situ hybridization (FISH), can confirm the presence of the deletion on chromosome 21. Clinical evaluation is necessary to assess the range and severity of symptoms present in the individual.
Treatment[edit | edit source]
There is no cure for Chromosome 21, monosomy 21q22, and treatment focuses on managing symptoms and improving the quality of life for affected individuals. This may include:
- Early intervention programs for developmental delays
- Special education services
- Physical therapy
- Speech therapy
- Medical management of congenital heart defects and other health issues
Prognosis[edit | edit source]
The prognosis for individuals with Chromosome 21, monosomy 21q22 varies widely depending on the nature and severity of symptoms. With appropriate support and treatment, many affected individuals can lead fulfilling lives.
See Also[edit | edit source]
Chromosome 21, monosomy 21q22 Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD